Literature DB >> 5538163

Pharmacologic studies of tritiated cytosine arabinoside (NSC-63878) in children.

J Z Finklestein, J Scher, M Karon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5538163

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  5 in total

Review 1.  Clinical pharmacokinetics of methotrexate in children.

Authors:  Y M Wang; T Fujimoto
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 2.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.

Authors:  A L Harris; C Potter; C Bunch; J Boutagy; D J Harvey; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

4.  The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.

Authors:  M L Slevin; E M Piall; G W Aherne; A Johnston; M C Sweatman; T A Lister
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

5.  The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.

Authors:  W R Mancini
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.